相似文献
1
Zinc lozenges reduce the duration of common cold symptoms.
Nutr Rev. 1997 Mar;55(3):82-5. doi: 10.1111/j.1753-4887.1997.tb01601.x.
2
Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.
Ann Intern Med. 1996 Jul 15;125(2):81-8. doi: 10.7326/0003-4819-125-2-199607150-00001.
3
The role of zinc lozenges in treatment of the common cold.
Ann Pharmacother. 1998 Jan;32(1):63-9. doi: 10.1345/aph.17128.
4
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.
Antimicrob Agents Chemother. 1984 Jan;25(1):20-4. doi: 10.1128/AAC.25.1.20.
5
Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial.
JAMA. 1998 Jun 24;279(24):1962-7. doi: 10.1001/jama.279.24.1962.
6
Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial.
Altern Ther Health Med. 2006 Jan-Feb;12(1):34-8.
7
Zinc gluconate lozenges for common cold. A double-blind clinical trial.
Dan Med Bull. 1990 Jun;37(3):279-81.
8
Sugar-free zinc gluconate glycine lozenges (Cold-Eeze) do not adversely affect glucose control in patients with type 1 or type 2 diabetes mellitus.
Am J Ther. 2001 Jul-Aug;8(4):247-52. doi: 10.1097/00045391-200107000-00007.
9
Effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) against the common cold in school-aged subjects: a retrospective chart review.
Am J Ther. 2002 Nov-Dec;9(6):472-5. doi: 10.1097/00045391-200211000-00002.
10
Safety of zinc gluconate glycine (Cold-Eeze) in a geriatric population: a randomized, placebo-controlled, double-blind trial.
Am J Ther. 2005 Nov-Dec;12(6):612-7. doi: 10.1097/01.mjt.0000179115.04316.18.
本文引用的文献
1
Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.
Ann Intern Med. 1996 Jul 15;125(2):81-8. doi: 10.7326/0003-4819-125-2-199607150-00001.
2
Excessive intake of zinc impairs immune responses.
JAMA. 1984 Sep 21;252(11):1443-6.
3
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.
Antimicrob Agents Chemother. 1984 Jan;25(1):20-4. doi: 10.1128/AAC.25.1.20.
4
Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance.
Am J Med Sci. 1986 Dec;292(6):344-9. doi: 10.1097/00000441-198612000-00002.
5
Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.
J Antimicrob Chemother. 1987 Dec;20(6):893-901. doi: 10.1093/jac/20.6.893.
6
Stability constants of zinc complexes affect common cold treatment results.
Antimicrob Agents Chemother. 1988 Apr;32(4):606-7. doi: 10.1128/AAC.32.4.606.
7
Zinc for the common cold.
Antimicrob Agents Chemother. 1988 Apr;32(4):605-6. doi: 10.1128/AAC.32.4.605.
8
Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults.
Antimicrob Agents Chemother. 1987 Aug;31(8):1263-5. doi: 10.1128/AAC.31.8.1263.
9
Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.
Antimicrob Agents Chemother. 1987 Aug;31(8):1183-7. doi: 10.1128/AAC.31.8.1183.
10
Failure of zinc gluconate in treatment of acute upper respiratory tract infections.
Antimicrob Agents Chemother. 1989 May;33(5):646-8. doi: 10.1128/AAC.33.5.646.
Zotero 插件